Document is current
Any future updates will be listed below
-
Authors
Sanabria-Salas, María Carolina https://orcid.org/0000-0002-7946-2026
Rivera-Herrera, Ana Lucía
Manotas, María Carolina
Guevara, Gonzalo
Gómez, Ana Milena https://orcid.org/0000-0002-4739-5260
Medina, Vilma
Tapiero, Sandra
Huertas, Antonio
Nuñez, Marcela
Torres, Miguel Zamir
Riaño-Moreno, Julián
Parra-Medina, Rafael
Mejía, Juan Carlos
Carvajal-Carmona, Luis G. https://orcid.org/0000-0001-7129-2918
- License Information
-
More Information
Article History
Received: 5 July 2024
Revised: 11 January 2025
Accepted: 3 February 2025
First Online: 10 March 2025
Competing interests
: The authors declare no competing interests.
: The Scientific Committee of the Instituto Nacional de Cancerología, Colombia (INC-C), approved the implementation of a Hereditary Cancer Program in 2017 as a Quality Improvement Project to provide germline genetic testing as a standard-of-care service for patients with cancer and suspected hereditary conditions. Participants in this institutional Program consented to donate biological samples to the National Tumor Biobank Terry Fox (BNTTF, in Spanish: Banco Nacional de Tumores Terry Fox), managed by the INC-C, and signed informed consent for DNA biobanking and future research studies. The Program’s registry is being implemented for epidemiological reporting.
